Zoledronic acid and radiation: toxicity, synergy or radiosensitization?
Authors:
- 24 July 2012
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 15 (4) , 300-306
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chemical genoprotection: reducing biological damage to as low as reasonably achievable levelsDentomaxillofacial Radiology, 2011
- Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone diseaseEuropean Journal of Cancer, 2010
- Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonatesLung Cancer, 2010
- Liposoluble antioxidants provide an effective radioprotective barrierBritish Journal of Radiology, 2009
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?European Journal of Cancer, 2009
- Synergistic Effects of Radiation and β-Lapachone in DU-145 Human Prostate Cancer CellsIn VitroRadiation Research, 2006
- Radiosensitizing effect of zoledronic acid in small cell lung cancerLung Cancer, 2005
- Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesLung Cancer, 2005
- Radiosensitizing effect of cisplatin in prostate cancer cell linesCancer Letters, 1996
- Protective Effects of Vitamins C and E Against γ-ray-induced Chromosomal Damage in MouseInternational Journal of Radiation Biology, 1993